Leading innovator in the design of automated minimally invasive neuro and spinal tissue and tumor removal instruments.
NICO Announces First Patient Enrolled in Phase 3 Randomized Controlled Trial on Early Intervention of Hemorrhagic Stroke, Deadliest Form of Stroke
Indianapolis Medical device maker NICO Corporation today announced the enrollment of the first patient in the ENRICH (Early MiNimally-invasive Removal of ICH) randomized clinical trial.
To provide medical device and technology companies with a greater perspective on successfully navigating VACs, we spoke with four River Cities’ med tech portfolio companies that have dedicated countless hours to mastering the pathway to get innovative products in front of and approved by these ever-vigilant committees.
Two Major Publications Reveal New Study Data Showing Patients with Deadliest Form of Stroke Now Have Second Chance at Life
New evidence in hemorrhagic stroke care suggests there may now be an answer for safely treating the deadliest, most costly and debilitating form of stroke through early surgical intervention.
Gigi Gelvosa is an OR nurse at Seton Brain & Spine in Austin, Texas. She’s not just any OR nurse — she’s the nurse of Dr. Ziu, BrainPath user. Recently, though, she became the patient of Dr. Ziu after suffering a hemorrhagic stroke…and was the recipient of a BrainPath surgery. Watch this TV 7 news story that shares her story or survival. Dr. Ziu says THIS tube is not just any tube and without it, his nurse’s hemorrhage would have been inoperable.
Neurosurgery Device Maker Completes $15 Million Capital Raise to Address Increasing Market Demand of New Technologies for Tumor and Stroke
NICO Corporation, an Indianapolis-based neurosurgery medical device manufacturer, recently completed a $15 million capital raise important to the expansion of newly developed markets created by their technologies and systems approach to subcortical brain surgery.